Leukocyte reduction of red cells when transfusing patients with autoimmune hemolytic anemia: a strategy to decrease the incidence of confounding transfusion reactions
By: J.A. Lumadue, R.S. Shirey, T.S. Kickler and P.M. Ness
Paid access
|Nov 2020Authors
J.A. Lumadue
Clinical Fellow, Department of Pathology, Division of Transfusion Medicine, The Johns Hopkins Hospital, Baltimore, United States
R.S. Shirey
Technical Specialist, Division of Transfusion Medicine, The Johns Hopkins Hospital, Baltimore, United States
T.S. Kickler
Division of Transfusion Medicine, The Johns Hopkins Hospital, Baltimore, United States
P.M. Ness
Division of Transfusion Medicine, The Johns Hopkins Hospital, Baltimore, United States
DOI: https://doi.org/10.21307/immunohematology-2019-752 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 84 - 86
Published on: Nov 10, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 J.A. Lumadue, R.S. Shirey, T.S. Kickler, P.M. Ness, published by American National Red Cross
This work is licensed under the Creative Commons License.